Literature DB >> 19142294

Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings.

Mathieu Forster1, Christopher Bailey, Martin W G Brinkhof, Claire Graber, Andrew Boulle, Mark Spohr, Eric Balestre, Margaret May, Olivia Keiser, Andreas Jahn, Matthias Egger.   

Abstract

OBJECTIVE: To describe the electronic medical databases used in antiretroviral therapy (ART) programmes in lower-income countries and assess the measures such programmes employ to maintain and improve data quality and reduce the loss of patients to follow-up.
METHODS: In 15 countries of Africa, South America and Asia, a survey was conducted from December 2006 to February 2007 on the use of electronic medical record systems in ART programmes. Patients enrolled in the sites at the time of the survey but not seen during the previous 12 months were considered lost to follow-up. The quality of the data was assessed by computing the percentage of missing key variables (age, sex, clinical stage of HIV infection, CD4+ lymphocyte count and year of ART initiation). Associations between site characteristics (such as number of staff members dedicated to data management), measures to reduce loss to follow-up (such as the presence of staff dedicated to tracing patients) and data quality and loss to follow-up were analysed using multivariate logit models.
FINDINGS: Twenty-one sites that together provided ART to 50 060 patients were included (median number of patients per site: 1000; interquartile range, IQR: 72-19 320). Eighteen sites (86%) used an electronic database for medical record-keeping; 15 (83%) such sites relied on software intended for personal or small business use. The median percentage of missing data for key variables per site was 10.9% (IQR: 2.0-18.9%) and declined with training in data management (odds ratio, OR: 0.58; 95% confidence interval, CI: 0.37-0.90) and weekly hours spent by a clerk on the database per 100 patients on ART (OR: 0.95; 95% CI: 0.90-0.99). About 10 weekly hours per 100 patients on ART were required to reduce missing data for key variables to below 10%. The median percentage of patients lost to follow-up 1 year after starting ART was 8.5% (IQR: 4.2-19.7%). Strategies to reduce loss to follow-up included outreach teams, community-based organizations and checking death registry data. Implementation of all three strategies substantially reduced losses to follow-up (OR: 0.17; 95% CI: 0.15-0.20).
CONCLUSION: The quality of the data collected and the retention of patients in ART treatment programmes are unsatisfactory for many sites involved in the scale-up of ART in resource-limited settings, mainly because of insufficient staff trained to manage data and trace patients lost to follow-up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19142294      PMCID: PMC2649575          DOI: 10.2471/blt.07.049908

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  17 in total

1.  An information system and medical record to support HIV treatment in rural Haiti.

Authors:  Hamish S F Fraser; Darius Jazayeri; Patrice Nevil; Yusuf Karacaoglu; Paul E Farmer; Evan Lyon; Mary Kay C Smith Fawzi; Fernet Leandre; Sharon S Choi; Joia S Mukherjee
Journal:  BMJ       Date:  2004-11-13

2.  Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts.

Authors:  François Dabis; Eric Balestre; Paula Braitstein; Paolo Miotti; W G Martin Brinkhof; Martin Schneider; Mauro Schechter; Christian Laurent; Andrew Boulle; Charles Kabugo; Gorana Capkun; Catherine Seyler; James McIntyre; Eduardo Sprinz; David Bangsberg; Stefan Van der Borght; Matthias Egger
Journal:  Int J Epidemiol       Date:  2005-09-12       Impact factor: 7.196

3.  Implementing electronic medical record systems in developing countries.

Authors:  Hamish S F Fraser; Paul Biondich; Deshen Moodley; Sharon Choi; Burke W Mamlin; Peter Szolovits
Journal:  Inform Prim Care       Date:  2005

Review 4.  Applications of multiple imputation in medical studies: from AIDS to NHANES.

Authors:  J Barnard; X L Meng
Journal:  Stat Methods Med Res       Date:  1999-03       Impact factor: 3.021

5.  Installing and implementing a computer-based patient record system in sub-Saharan Africa: the Mosoriot Medical Record System.

Authors:  Joseph K Rotich; Terry J Hannan; Faye E Smith; John Bii; Wilson W Odero; Nguyen Vu; Burke W Mamlin; Joseph J Mamlin; Robert M Einterz; William M Tierney
Journal:  J Am Med Inform Assoc       Date:  2003-03-28       Impact factor: 4.497

6.  Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Authors:  Jeffrey S A Stringer; Isaac Zulu; Jens Levy; Elizabeth M Stringer; Albert Mwango; Benjamin H Chi; Vilepe Mtonga; Stewart Reid; Ronald A Cantrell; Marc Bulterys; Michael S Saag; Richard G Marlink; Alwyn Mwinga; Tedd V Ellerbrock; Moses Sinkala
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

7.  Cooking up an open source EMR for developing countries: OpenMRS - a recipe for successful collaboration.

Authors:  Burke W Mamlin; Paul G Biondich; Ben A Wolfe; Hamish Fraser; Darius Jazayeri; Christian Allen; Justin Miranda; William M Tierney
Journal:  AMIA Annu Symp Proc       Date:  2006

8.  Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Authors:  Martin W G Brinkhof; François Dabis; Landon Myer; David R Bangsberg; Andrew Boulle; Denis Nash; Mauro Schechter; Christian Laurent; Olivia Keiser; Margaret May; Eduardo Sprinz; Matthias Egger; Xavier Anglaret
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

9.  Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.

Authors:  Olivia Keiser; Kathryn Anastos; Mauro Schechter; Eric Balestre; Landon Myer; Andrew Boulle; David Bangsberg; Hapsatou Touré; Paula Braitstein; Eduardo Sprinz; Denis Nash; Mina Hosseinipour; François Dabis; Margaret May; Martin W G Brinkhof; Matthias Egger
Journal:  Trop Med Int Health       Date:  2008-03-27       Impact factor: 2.622

10.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Authors:  Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

View more
  79 in total

1.  Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings.

Authors:  A Spaar; C Graber; F Dabis; A Coutsoudis; L Bachmann; J McIntyre; M Schechter; H W Prozesky; S Tuboi; D Dickinson; N Kumarasamy; M Pujdades-Rodriquez; E Sprinz; H J Schilthuis; P Cahn; N Low; M Egger
Journal:  AIDS Care       Date:  2010-06

2.  Mortality after failure of antiretroviral therapy in sub-Saharan Africa.

Authors:  Olivia Keiser; Hannock Tweya; Paula Braitstein; François Dabis; Patrick MacPhail; Andrew Boulle; Denis Nash; Robin Wood; Ruedi Lüthi; Martin W G Brinkhof; Mauro Schechter; Matthias Egger
Journal:  Trop Med Int Health       Date:  2009-12-09       Impact factor: 2.622

3.  An e-health driven laboratory information system to support HIV treatment in Peru: E-quity for laboratory personnel, health providers and people living with HIV.

Authors:  Patricia J García; Javier H Vargas; Patricia Caballero N; Javier Calle V; Angela M Bayer
Journal:  BMC Med Inform Decis Mak       Date:  2009-12-10       Impact factor: 2.796

Review 4.  Innovation in sexually transmitted disease and HIV prevention: internet and mobile phone delivery vehicles for global diffusion.

Authors:  Dallas Swendeman; Mary Jane Rotheram-Borus
Journal:  Curr Opin Psychiatry       Date:  2010-03       Impact factor: 4.741

5.  Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children.

Authors:  Sophie Desmonde; Fatoumata Dicko; Fla Koueta; Tanoh Eboua; Eric Balestre; Clarisse Amani-Bosse; Edmond A Aka; Koko Lawson-Evi; Madeleine Amorissani-Folquet; Kouadio Kouakou; Siriatou Koumakpai; Lorna Renner; Haby Signaté Sy; Valériane Leroy
Journal:  AIDS       Date:  2014-07-17       Impact factor: 4.177

6.  Lessons learned while implementing an HIV/AIDS care and treatment program in rural Mozambique.

Authors:  Troy D Moon; Janeen R Burlison; Mohsin Sidat; Paulo Pires; Wilson Silva; Manuel Solis; Michele Rocha; Chiqui Arregui; Eric J Manders; Alfredo E Vergara; Sten H Vermund
Journal:  Retrovirology (Auckl)       Date:  2010-04-23

7.  An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs.

Authors:  Benjamin H Chi; Ronald A Cantrell; Albert Mwango; Andrew O Westfall; Wilbroad Mutale; Mohammed Limbada; Lloyd B Mulenga; Sten H Vermund; Jeffrey S A Stringer
Journal:  Am J Epidemiol       Date:  2010-03-10       Impact factor: 4.897

8.  Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces.

Authors:  Geoffrey Fatti; Ashraf Grimwood; Peter Bock
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

9.  Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.

Authors:  Mattia C F Prosperi; Michal Rosen-Zvi; André Altmann; Maurizio Zazzi; Simona Di Giambenedetto; Rolf Kaiser; Eugen Schülter; Daniel Struck; Peter Sloot; David A van de Vijver; Anne-Mieke Vandamme; Anders Sönnerborg
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

10.  Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Authors:  Elena Losina; Hapsatou Touré; Lauren M Uhler; Xavier Anglaret; A David Paltiel; Eric Balestre; Rochelle P Walensky; Eugène Messou; Milton C Weinstein; François Dabis; Kenneth A Freedberg
Journal:  PLoS Med       Date:  2009-10-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.